ConductScience.org, home

Paper648557

Uptake and subcellular localization of daunorubicin and adriamycin in cultured fibroblasts.

Noel G and 3 others. Eur J Cancer (1965), 1978. Cited by 104 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Uptake and subcellular localization of daunorubicin and adriamycin in cultured fibroblasts. Papers, record 648557. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/648557

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Uptake and subcellular localization of daunorubicin and adriamycin in cultured fibroblasts.
PubMed
Journal
Eur J Cancer (1965)
PubMed
Year
1978
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
104
iCite
Relative citation ratio, by iCite
3.83
iCite
Revised in PubMed
2019-09-07
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Noel GG
2Peterson CC
3Trouet AA
4Tulkens PP

Source PubMed

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DaunorubicinMajor topic
DoxorubicinMajor topic
FibroblastsMajor topic
Animals
Cell Nucleus
Cells, Cultured
Kinetics
Lysosomes
Rats
Subcellular Fractions
Time Factors

Source PubMed

Cited by26

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 104 citations.

PMIDTitleJournalYearIn PapersSource
41,155,892Lysosomal Drug Sequestration Mediated by ABC Transporters and Drug Resistance.Pharmaceutics2025https://conductscience.org/library/papers/41155892PubMed
36,899,844What Is the Significance of Lysosomal-Mediated Resistance to Imatinib?Cells2023https://conductscience.org/library/papers/36899844PubMed
31,683,643The Lysosomal Sequestration of Tyrosine Kinase Inhibitors and Drug Resistance.Biomolecules2019https://conductscience.org/library/papers/31683643PubMed
22,563,426Importance of intracellular pH in determining the uptake and efficacy of the weakly basic chemotherapeutic drug, doxorubicin.PLoS One2012https://conductscience.org/library/papers/22563426PubMed
10,070,878The pH partition theory predicts the accumulation and toxicity of doxorubicin in normal and low-pH-adapted cells.Br J Cancer1999https://conductscience.org/library/papers/10070878PubMed
6,961,971Uptake and metabolism of daunorubicin by human leukemia cells.Cancer Chemother Pharmacol1982https://conductscience.org/library/papers/6961971PubMed
6,958,392Metabolism of daunorubicin in sensitive and resistant Ehrlich ascites tumor cells. Determination by high pressure liquid chromatography.Cancer Chemother Pharmacol1982https://conductscience.org/library/papers/6958392PubMed
6,941,824Individual nuclear uptake patterns for adriamycin and daunomycin in human leukemia and lymphoma cells.Blut1981https://conductscience.org/library/papers/6941824PubMed
6,733,840Cytofluorescence localization of adriamycin in resistant colon cancer cells.Cancer Chemother Pharmacol1984https://conductscience.org/library/papers/6733840PubMed
6,690,077Uptake, metabolism, and cytotoxicity of doxorubicin in human Ewing's sarcoma and rhabdomyosarcoma cells.Cancer Chemother Pharmacol1984https://conductscience.org/library/papers/6690077PubMed
6,627,597Comparative studies of the uptake of daunorubicin in sensitive and resistant P388 cell lines by flow cytometry and biochemical extraction procedures.Cancer Chemother Pharmacol1983https://conductscience.org/library/papers/6627597PubMed
6,446,523Characteristics and effect of antiinflammatory drugs on adriamycin-induced inflammation in the mouse paw.Inflammation1980https://conductscience.org/library/papers/6446523PubMed
4,054,202Cellular pharmacokinetics of daunorubicin: uptake by leukaemic cells in vivo and fate.Eur J Clin Pharmacol1985https://conductscience.org/library/papers/4054202PubMed
4,006,046Lysosomal alterations in heart and liver of mice treated with doxorubicin.Cancer Chemother Pharmacol1985https://conductscience.org/library/papers/4006046PubMed
3,770,010Hepatic metabolism of doxorubicin in mice and rats.Eur J Drug Metab Pharmacokinet1986https://conductscience.org/library/papers/3770010PubMed
3,742,710Doxorubicin binds in a cooperative manner to myocardial cells. Two binding sites.Cancer Chemother Pharmacol1986https://conductscience.org/library/papers/3742710PubMed
3,579,258Influence of conversion of penicillin G into a basic derivative on its accumulation and subcellular localization in cultured macrophages.Antimicrob Agents Chemother1987https://conductscience.org/library/papers/3579258PubMed
3,466,179Immobilized doxorubicin increases the complement susceptibility of human melanoma cells by protecting complement component C3b against inactivation.Proc Natl Acad Sci U S A1986https://conductscience.org/library/papers/3466179PubMed
2,295,112Intracellular concentrations of anti cancer drugs in leukemic cells in vitro vs in vivo.Cancer Chemother Pharmacol1990https://conductscience.org/library/papers/2295112PubMed
2,254,382Adriamycin uptake and metabolism in organotypic culture of A549 human adenocarcinoma cells according to the exposure time.J Cancer Res Clin Oncol1990https://conductscience.org/library/papers/2254382PubMed

See all 26 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/648557

GET https://conductscience.org/api/papers/v1/648557/cited_by?page=2